$145.98
+2.1%Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Chief Executive Officer, President & Director
Compensation
$5,685,108
Executive Vice President & President of Acute Care Division
Compensation
$2,439,443
Executive Vice President & President of Behavioral Health Care Division
Compensation
$2,196,805
Executive Vice President, Chief Financial Officer & Secretary
Compensation
$2,596,736
Founder & Executive Chairman of the Board
Compensation
$3,064,714
Senior Vice President & General Counsel
Senior Vice President of Finance - Acute Care Division
Senior Vice President of Finance - Behavioral Health Division
Senior Vice President of Human Resources & Corporate Officer
Senior Vice President of Strategic Services
Vice President of Investor Relations
During the last 12 months, insiders have sold $378K worth of UHS shares, with no buying activity reported.
0
0.00
674
128.10K
-128K
-$128K
0
0.00
0
0.00
+0
+$0
0
0.00
1.1K
249.60K
-250K
-$250K
0
0.00
0
0.00
+0
+$0
No buying activity
Sussman Elliot J Md Mba
Director
$346K
Nimetz Warren J.
Director
$32K
Strong bearish signal with $378K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
2 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Persistent selling pressure: Consistent insider selling with weak buy/sell ratio suggests insiders may be capitalizing on current valuation. Exercise caution and review recent earnings quality and management commentary.
UHS - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 09, 2026 | May 20, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 03, 2025 | May 14, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 04, 2024 | May 15, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 06, 2023 | April 06, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 07, 2022 | May 18, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 07, 2021 | May 19, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 09, 2020 | May 20, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 04, 2019 | May 15, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 05, 2018 | May 16, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 06, 2017 | May 17, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.